Security key
G0360L100
- Security type / class
- Equity / SHS
- Total 13F shares
- 414,323
- Total 13F value
- $119,000
- Share change
- +122,789
- SEC-reported price per share
- $0.29
- Number of holders
- 10
- Value change
- +$11,602
- Number of buys
- 7
- Number of sells
- 6
Report period
Q3 2022
Institutions
10
Top holders
10
CYTO full security history
Ownership snapshot
Full 13F holder table
Altamira Therapeutics Ltd. SEC filings
Altamira Therapeutics Ltd. company facts
Broader feeds
Ownership snapshot
Top reported holders of CYTO - ALTAMIRA THERAPEUTICS LTD - SHS (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GROUP ONE TRADING LLC
Disclosed value leader
GROUP ONE TRADING LLC
Comparable rows
0/10
Latest evidence
30 Jun 2022
13F
Highest disclosed value: $39,000
10 rows are not safely comparable across share classes.
Showing 1-6 of 10 holder rows.
Quick read
GROUP ONE TRADING LLC has the largest disclosed position value at $39K.
0 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GROUP ONE TRADING LLC's linked filing trail.
Disclosed position value
Top 5
GROUP ONE TRADING LLC
$39K
Ikarian Capital, LLC
$36K
MORGAN STANLEY
$13K
UBS Group AG
$13K
Tower Research Capital LLC (TRC)
$11K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 10 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GROUP ONE TRADING LLC |
13F
Company
|
—
denominator unverified
|
$39,000
80,605 shares
|
— | 30 Jun 2022 |
| Ikarian Capital, LLC |
13F
Company
|
—
denominator unverified
|
$36,000
75,000 shares
|
— | 30 Jun 2022 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$13,000
26,300 shares
|
— | 30 Jun 2022 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$13,000
26,063 shares
|
— | 30 Jun 2022 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
—
denominator unverified
|
$11,000
22,649 shares
|
— | 30 Jun 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$9,000
18,871 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
414,323
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
10
Q3 2022 holders
10
Holder diff
0
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|